Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:05 pm Sale | 2024-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | Allostery Investments LP | 55,840 0.500% | -22,415 (-28.64%) | Filing History |
| 2024-11-14 12:04 pm Purchase | 2024-09-30 | 13G | Oruka Therapeutics Inc. ORKA | Allostery Investments LP | 43,557 0.300% | 43,557 (New Position) | Filing History |
| 2024-05-13 12:38 pm Purchase | 2024-05-01 | 13G | Avalo Therapeutics, Inc. AVTX | Allostery Investments LP | 78,255 7.600% | 78,255 (New Position) | Filing History |
| 2024-04-15 5:29 pm Purchase | 2024-04-03 | 13G | ARCA biopharma, Inc. ABIO | Allostery Investments LP | 88,751 7.300% | 88,751 (New Position) | Filing History |